This interaction inhibits CD4+/CD8+ tumor-infiltrating T-lymphocytes (CD4+/CD8+ TILs), which results in a decrease in cytokines, such as Interleucin-2 (IL-2), interferon gamma (IFN-γ) and tumor necrosis factor (TNF). The gene discussed is IFNG; the disease is neoplasm.